Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sky 31 Convention

Nov 17, 2022 10:30 AM - Nov 18, 2022 6:00 PM

Conference A, 300, Olympic-ro, Songpa-g, Seoul 05551, Korea, Republic of

2022 NIFDS -DIA Conference : New Logics of High-Tech Drug Development and Quality Challenges

Session 2: Development Strategy of Complex Generics

Session Chair(s)

So Hee  Kim, PhD

So Hee Kim, PhD

Director / Ministry of Food and Drug Safety

National Institute of Food and Drug Safety Evaluation (NIFDS), Korea, Republic of

The challenges faced with complex generics development using advanced technology such as liposome, micelle, transdermal patch and metered dose inhalers etc., we will discuss the characteristics of the active ingredient and formulation to prove equivalence to a reference drug in terms of efficacy, safety, and quality. The regulatory landscape and case studies will be discussed.

Speaker(s)

Choong Yul  Ahn

New Concept in the Method of Equivalence Study and Cases

Choong Yul Ahn

Ministry of Food and Drug Safety, Korea, Republic of

Senior Reviewer of Bioequivalence Evaluation Division

Younghwan  Park

Case Studies: Liposomes and Nanoparticles

Younghwan Park

SN BioScience Inc., Korea, Republic of

CEO & Founder

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.